Novo Nordisk Capital Markets Day
Executive management gives a full review of strategy, operations and long-term financial targets — Novo Nordisk's first such day since 2024 and its first under a reset obesity strategy. New multi-year margin and pipeline targets are the kind of guidance that reprices the stock in one session.
- News
- 4/5
- Markets
- 4/5
- Overall
- 4/5

